Dr. Jonathan Richard McDonagh, MD

Dr. McDonagh practices at Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services.

Dr. McDonagh's NPI, 1972609949, was assigned on September 16, 2006. Dr. McDonagh graduated from University of Vermont College of Medicine in 2001. Dr. McDonagh holds Alaska license 5821.

Dr. McDonagh's primary practice is Providence Alaska Medical Center, at 3200 Providence Drive, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-2211.

Dr. McDonagh's primary practice is Providence Alaska Medical Center in Anchorage, Alaska, part of Providence Health & Services. Dr. McDonagh is also affiliated with Alaska Regional Hospital. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. McDonagh to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McDonagh practices, 8 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. McDonagh's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dmand AI has Dr. McDonagh's licenses on file in 2 states: Alaska and Michigan.

CMS data shows 2,261 Medicare services from Dr. McDonagh across 37 procedure codes in 2024, for 1,024 Medicare patients. Medicare paid $271,417 for them.

CMS counts 1,024 Medicare patients who saw Dr. McDonagh in 2024. The largest group is 65 to 74, with 417 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.64, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McDonagh's median patient age at 73, with 41% women.

In 2024, Dr. McDonagh wrote 2,104 Medicare Part D claims for 318 patients. 87% of them were for generic drugs. CMS names the drug for 1,913 of them, across 31 drugs with 11 or more claims each, at $342,332 in total drug cost. In 2023, CMS named 1,767 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. McDonagh for performance year 2024, reported as part of a group. Dr. McDonagh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McDonagh as offering telehealth. CMS counts 89 procedures of coronary angioplasty and stenting by Dr. McDonagh, more than 95% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. McDonagh in 2015.

CMS Open Payments shows 263 general payments to Dr. McDonagh from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 64% of the total. Abbott Laboratories paid the most, $8,993.

Dr. McDonagh graduated from University of Vermont College of Medicine in 2001.